Holding types
Countries
Sectors
Analyst ratings
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Disruptive Theme of the Week – Breakthroughs in Medicine
CANC
etftrends.com21 November 2024
Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.
Inside Tema ETFs' New Oncology ETF (CANC)
CANC
Zacks Investment Research25 August 2023
Oncology treatment has witnessed remarkable progress due to the relentless efforts of pharmaceutical companies in recent times.
FAQ
- What is CANC ETF?
- Does CANC pay dividends?
- What stocks are in CANC ETF?
- What is the current assets under management for CANC?
- What is CANC average volume?
- What is CANC expense ratio?
- What is CANC inception date?
What is CANC ETF?
CANC ETF is an exchange-traded fund that focuses on companies involved in cancer research and treatment. It aims to provide investors with exposure to the growing healthcare sector, particularly in oncology, by investing in stocks of firms developing innovative cancer therapies and technologies.
Does CANC pay dividends?
Yes, the Tema Oncology ETF does pays dividends, with
the most recent payment being
$0.15
per share. The last ex-dividend date was on 13 December 2023, and the next ex-dividend date has not been announced yet
What stocks are in CANC ETF?
As of today, Tema Oncology ETF inlcudes 50 holdings, with 44 of them being companies from 8 different countries and 1 sectors. The most weighted holdings are Gilead Sciences (5.42%), Regeneron Pharmaceuticals (5.39%) and ASTRAZENECA PLC (5.21%)
What is the current assets under management for CANC?
Assets under management of Tema Oncology ETF is $48 M
What is CANC average volume?
Average volume of Tema Oncology ETF is $20 K
What is CANC expense ratio?
Expense ratio of Tema Oncology ETF is 0.75%
What is CANC inception date?
Inception date of Tema Oncology ETF is 14 August 2023